| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7280572 | Brain, Behavior, and Immunity | 2016 | 26 Pages |
Abstract
In conclusion, the physical but not the affective or cognitive dimension of fatigue seems associated with cortisol dysregulations in breast cancer patients undergoing adjuvant therapy, characterized by an unaffected cortisol level in the morning but blunted decline to the evening level. Research focusing on disturbances of the cortisol rhythm and HPA dysregulations during and after cancer treatment may open new strategies to reduce cancer-related fatigue.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Martina E. Schmidt, Johanna Semik, Nina Habermann, Joachim Wiskemann, Cornelia M. Ulrich, Karen Steindorf,